The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells
Calcium ion is one of the most important second messengers of cellular signal transduction including hypoxia-elicited signals. In this study, we investigated the effects of the L-type calcium channel blockers such as nifedipine, efonidipine cilnidipine, diltiazem, and verapamil, on the activity of h...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2009-03, Vol.606 (1), p.130-136 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 136 |
---|---|
container_issue | 1 |
container_start_page | 130 |
container_title | European journal of pharmacology |
container_volume | 606 |
creator | Oda, Seiko Oda, Tomoyuki Takabuchi, Satoshi Nishi, Kenichiro Wakamatsu, Takuhiko Tanaka, Tomoharu Adachi, Takehiko Fukuda, Kazuhiko Nohara, Ryuji Hirota, Kiichi |
description | Calcium ion is one of the most important second messengers of cellular signal transduction including hypoxia-elicited signals. In this study, we investigated the effects of the L-type calcium channel blockers such as nifedipine, efonidipine cilnidipine, diltiazem, and verapamil, on the activity of hypoxia-inducible factor-1 (HIF-1), a key transcription factor in control of hypoxia-induced gene expression. Using the lung carcinoma cell line A549 cells, human aortic smooth muscle cells, and human umbilical vein endothelial cells, we demonstrated that cilnidipine exclusively suppressed HIF-1 activity and the expressions of downstream genes in a cell-type specific manner. We also demonstrated that cilnidipine blocked the synthesis of the HIF-1α protein not by affecting activity of the intracellular hypoxia-sensing element prolyl hydroxylases but inhibiting activity of Akt and mitogen-activated protein kinase and that the inhibition is not dependent on the effect on calcium homeostasis. |
doi_str_mv | 10.1016/j.ejphar.2009.01.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67148311</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299909000636</els_id><sourcerecordid>67148311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-c3d73847a86c0a43fe6fc23a0227a21195ad426ceaf2dd9048d1920b727e938d3</originalsourceid><addsrcrecordid>eNp9kE2L2zAQhkVp6WY__kEpunRvTjWybFmXQlm63cJCL9uzmEhjolSxXckOzb-vQkJ7KwzM5XlfZh7G3oFYg4D2425Nu2mLaS2FMGsBZeQrtoJOm0pokK_ZSghQlTTGXLHrnHdCiMbI5i27AlNr1bXdis0vW-IOowvLnrstDgNFvomj-0mJuxCH4MMUBuKZIrk5HCgeeV6mKVHOlPn2OI2_A1Zh8IsLm0i8RzePiQPHEx7mIw8DP2B2S8RSSTHmW_amx5jp7rJv2I_HLy8PT9Xz96_fHj4_V0417Vy52uu6Uxq71glUdU9t72SNQkqNEsA06JVsHWEvvTdCdR6MFBstNZm68_UNuz_3Tmn8tVCe7T7k0wU40Lhk22pQXQ1QQHUGXRpzTtTbKYU9pqMFYU-27c6ebduTbSugjCyx95f-ZbMn_y900VuADxeg_I-xTzi4kP9yEqRppGgK9-nMUbFxCJRsdoEGRz6kYt36Mfz_kj-uPKGc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67148311</pqid></control><display><type>article</type><title>The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Oda, Seiko ; Oda, Tomoyuki ; Takabuchi, Satoshi ; Nishi, Kenichiro ; Wakamatsu, Takuhiko ; Tanaka, Tomoharu ; Adachi, Takehiko ; Fukuda, Kazuhiko ; Nohara, Ryuji ; Hirota, Kiichi</creator><creatorcontrib>Oda, Seiko ; Oda, Tomoyuki ; Takabuchi, Satoshi ; Nishi, Kenichiro ; Wakamatsu, Takuhiko ; Tanaka, Tomoharu ; Adachi, Takehiko ; Fukuda, Kazuhiko ; Nohara, Ryuji ; Hirota, Kiichi</creatorcontrib><description>Calcium ion is one of the most important second messengers of cellular signal transduction including hypoxia-elicited signals. In this study, we investigated the effects of the L-type calcium channel blockers such as nifedipine, efonidipine cilnidipine, diltiazem, and verapamil, on the activity of hypoxia-inducible factor-1 (HIF-1), a key transcription factor in control of hypoxia-induced gene expression. Using the lung carcinoma cell line A549 cells, human aortic smooth muscle cells, and human umbilical vein endothelial cells, we demonstrated that cilnidipine exclusively suppressed HIF-1 activity and the expressions of downstream genes in a cell-type specific manner. We also demonstrated that cilnidipine blocked the synthesis of the HIF-1α protein not by affecting activity of the intracellular hypoxia-sensing element prolyl hydroxylases but inhibiting activity of Akt and mitogen-activated protein kinase and that the inhibition is not dependent on the effect on calcium homeostasis.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2009.01.012</identifier><identifier>PMID: 19374868</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Biological and medical sciences ; Calcium - metabolism ; Calcium channel blocker ; Calcium Channel Blockers - pharmacology ; Cell Line, Tumor ; Dihydropyridines - pharmacology ; Gene Expression Regulation - drug effects ; Humans ; Hypoxia ; Hypoxia-inducible factor 1 (HIF-1) ; Hypoxia-Inducible Factor 1 - antagonists & inhibitors ; Hypoxia-Inducible Factor 1 - metabolism ; Intracellular Space - drug effects ; Intracellular Space - metabolism ; Medical sciences ; Oxygen - metabolism ; Pharmacology. Drug treatments ; Smooth muscle cell ; Stress, Physiological - drug effects ; Translation ; Vascular endothelial cell</subject><ispartof>European journal of pharmacology, 2009-03, Vol.606 (1), p.130-136</ispartof><rights>2009 Elsevier B.V.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-c3d73847a86c0a43fe6fc23a0227a21195ad426ceaf2dd9048d1920b727e938d3</citedby><cites>FETCH-LOGICAL-c456t-c3d73847a86c0a43fe6fc23a0227a21195ad426ceaf2dd9048d1920b727e938d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejphar.2009.01.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21295205$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19374868$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oda, Seiko</creatorcontrib><creatorcontrib>Oda, Tomoyuki</creatorcontrib><creatorcontrib>Takabuchi, Satoshi</creatorcontrib><creatorcontrib>Nishi, Kenichiro</creatorcontrib><creatorcontrib>Wakamatsu, Takuhiko</creatorcontrib><creatorcontrib>Tanaka, Tomoharu</creatorcontrib><creatorcontrib>Adachi, Takehiko</creatorcontrib><creatorcontrib>Fukuda, Kazuhiko</creatorcontrib><creatorcontrib>Nohara, Ryuji</creatorcontrib><creatorcontrib>Hirota, Kiichi</creatorcontrib><title>The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Calcium ion is one of the most important second messengers of cellular signal transduction including hypoxia-elicited signals. In this study, we investigated the effects of the L-type calcium channel blockers such as nifedipine, efonidipine cilnidipine, diltiazem, and verapamil, on the activity of hypoxia-inducible factor-1 (HIF-1), a key transcription factor in control of hypoxia-induced gene expression. Using the lung carcinoma cell line A549 cells, human aortic smooth muscle cells, and human umbilical vein endothelial cells, we demonstrated that cilnidipine exclusively suppressed HIF-1 activity and the expressions of downstream genes in a cell-type specific manner. We also demonstrated that cilnidipine blocked the synthesis of the HIF-1α protein not by affecting activity of the intracellular hypoxia-sensing element prolyl hydroxylases but inhibiting activity of Akt and mitogen-activated protein kinase and that the inhibition is not dependent on the effect on calcium homeostasis.</description><subject>Biological and medical sciences</subject><subject>Calcium - metabolism</subject><subject>Calcium channel blocker</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Cell Line, Tumor</subject><subject>Dihydropyridines - pharmacology</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia-inducible factor 1 (HIF-1)</subject><subject>Hypoxia-Inducible Factor 1 - antagonists & inhibitors</subject><subject>Hypoxia-Inducible Factor 1 - metabolism</subject><subject>Intracellular Space - drug effects</subject><subject>Intracellular Space - metabolism</subject><subject>Medical sciences</subject><subject>Oxygen - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Smooth muscle cell</subject><subject>Stress, Physiological - drug effects</subject><subject>Translation</subject><subject>Vascular endothelial cell</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE2L2zAQhkVp6WY__kEpunRvTjWybFmXQlm63cJCL9uzmEhjolSxXckOzb-vQkJ7KwzM5XlfZh7G3oFYg4D2425Nu2mLaS2FMGsBZeQrtoJOm0pokK_ZSghQlTTGXLHrnHdCiMbI5i27AlNr1bXdis0vW-IOowvLnrstDgNFvomj-0mJuxCH4MMUBuKZIrk5HCgeeV6mKVHOlPn2OI2_A1Zh8IsLm0i8RzePiQPHEx7mIw8DP2B2S8RSSTHmW_amx5jp7rJv2I_HLy8PT9Xz96_fHj4_V0417Vy52uu6Uxq71glUdU9t72SNQkqNEsA06JVsHWEvvTdCdR6MFBstNZm68_UNuz_3Tmn8tVCe7T7k0wU40Lhk22pQXQ1QQHUGXRpzTtTbKYU9pqMFYU-27c6ebduTbSugjCyx95f-ZbMn_y900VuADxeg_I-xTzi4kP9yEqRppGgK9-nMUbFxCJRsdoEGRz6kYt36Mfz_kj-uPKGc</recordid><startdate>20090315</startdate><enddate>20090315</enddate><creator>Oda, Seiko</creator><creator>Oda, Tomoyuki</creator><creator>Takabuchi, Satoshi</creator><creator>Nishi, Kenichiro</creator><creator>Wakamatsu, Takuhiko</creator><creator>Tanaka, Tomoharu</creator><creator>Adachi, Takehiko</creator><creator>Fukuda, Kazuhiko</creator><creator>Nohara, Ryuji</creator><creator>Hirota, Kiichi</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090315</creationdate><title>The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells</title><author>Oda, Seiko ; Oda, Tomoyuki ; Takabuchi, Satoshi ; Nishi, Kenichiro ; Wakamatsu, Takuhiko ; Tanaka, Tomoharu ; Adachi, Takehiko ; Fukuda, Kazuhiko ; Nohara, Ryuji ; Hirota, Kiichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-c3d73847a86c0a43fe6fc23a0227a21195ad426ceaf2dd9048d1920b727e938d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Calcium - metabolism</topic><topic>Calcium channel blocker</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Cell Line, Tumor</topic><topic>Dihydropyridines - pharmacology</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia-inducible factor 1 (HIF-1)</topic><topic>Hypoxia-Inducible Factor 1 - antagonists & inhibitors</topic><topic>Hypoxia-Inducible Factor 1 - metabolism</topic><topic>Intracellular Space - drug effects</topic><topic>Intracellular Space - metabolism</topic><topic>Medical sciences</topic><topic>Oxygen - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Smooth muscle cell</topic><topic>Stress, Physiological - drug effects</topic><topic>Translation</topic><topic>Vascular endothelial cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oda, Seiko</creatorcontrib><creatorcontrib>Oda, Tomoyuki</creatorcontrib><creatorcontrib>Takabuchi, Satoshi</creatorcontrib><creatorcontrib>Nishi, Kenichiro</creatorcontrib><creatorcontrib>Wakamatsu, Takuhiko</creatorcontrib><creatorcontrib>Tanaka, Tomoharu</creatorcontrib><creatorcontrib>Adachi, Takehiko</creatorcontrib><creatorcontrib>Fukuda, Kazuhiko</creatorcontrib><creatorcontrib>Nohara, Ryuji</creatorcontrib><creatorcontrib>Hirota, Kiichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oda, Seiko</au><au>Oda, Tomoyuki</au><au>Takabuchi, Satoshi</au><au>Nishi, Kenichiro</au><au>Wakamatsu, Takuhiko</au><au>Tanaka, Tomoharu</au><au>Adachi, Takehiko</au><au>Fukuda, Kazuhiko</au><au>Nohara, Ryuji</au><au>Hirota, Kiichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2009-03-15</date><risdate>2009</risdate><volume>606</volume><issue>1</issue><spage>130</spage><epage>136</epage><pages>130-136</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Calcium ion is one of the most important second messengers of cellular signal transduction including hypoxia-elicited signals. In this study, we investigated the effects of the L-type calcium channel blockers such as nifedipine, efonidipine cilnidipine, diltiazem, and verapamil, on the activity of hypoxia-inducible factor-1 (HIF-1), a key transcription factor in control of hypoxia-induced gene expression. Using the lung carcinoma cell line A549 cells, human aortic smooth muscle cells, and human umbilical vein endothelial cells, we demonstrated that cilnidipine exclusively suppressed HIF-1 activity and the expressions of downstream genes in a cell-type specific manner. We also demonstrated that cilnidipine blocked the synthesis of the HIF-1α protein not by affecting activity of the intracellular hypoxia-sensing element prolyl hydroxylases but inhibiting activity of Akt and mitogen-activated protein kinase and that the inhibition is not dependent on the effect on calcium homeostasis.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19374868</pmid><doi>10.1016/j.ejphar.2009.01.012</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2009-03, Vol.606 (1), p.130-136 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_67148311 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Biological and medical sciences Calcium - metabolism Calcium channel blocker Calcium Channel Blockers - pharmacology Cell Line, Tumor Dihydropyridines - pharmacology Gene Expression Regulation - drug effects Humans Hypoxia Hypoxia-inducible factor 1 (HIF-1) Hypoxia-Inducible Factor 1 - antagonists & inhibitors Hypoxia-Inducible Factor 1 - metabolism Intracellular Space - drug effects Intracellular Space - metabolism Medical sciences Oxygen - metabolism Pharmacology. Drug treatments Smooth muscle cell Stress, Physiological - drug effects Translation Vascular endothelial cell |
title | The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A39%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20calcium%20channel%20blocker%20cilnidipine%20selectively%20suppresses%20hypoxia-inducible%20factor%201%20activity%20in%20vascular%20cells&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Oda,%20Seiko&rft.date=2009-03-15&rft.volume=606&rft.issue=1&rft.spage=130&rft.epage=136&rft.pages=130-136&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2009.01.012&rft_dat=%3Cproquest_cross%3E67148311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67148311&rft_id=info:pmid/19374868&rft_els_id=S0014299909000636&rfr_iscdi=true |